시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 탈모증 시장 보고서(2025년)
Alopecia Global Market Report 2025
상품코드 : 1824572
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

탈모증 시장 규모는 향후 수년간 안정된 성장이 예상됩니다. 2029년에는 CAGR 4.4%를 나타내 136억 4,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 고령화 인구 증가, 미용에 대한 관심 증가, 라이프스타일 요인 증가, 헬스케어 지출 증가에 기인하는 것으로 예상됩니다. 예측 기간의 주요 동향으로는 치료 옵션의 진보, 생명공학의 혁신, AI(AI) 및 머신러닝(ML) 조사에 대한 이용 확대 등이 있습니다.

향후 5년간의 성장률 4.4%라고 하는 예측은 전회 예측으로부터 0.2%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과는 이스라엘과 이탈리아에서 수입되는 JAK 억제제 및 레이저 치료 장비에 대한 접근을 제한하고, 발모의 성과를 악화시키고, 삼모과 클리닉의 비용을 증가시킬 수 있기 때문에 미국의 피부과에 큰 과제가 될 수 있습니다. 또한, 상호관세와 무역마찰의 격화와 제한에 의한 세계경제와 무역에 대한 악영향에 의해 그 영향은 보다 광범위하게 미칠 것으로 예측됩니다.

탈모의 유병률 증가가 예상되기 때문에 향후 수년간 탈모증 시장 성장이 촉진될 것으로 예측됩니다. 탈모는 전형적인 성장 지역에서 모발이 부분적으로 또는 완전히 손실되는 것을 특징으로하며, 많은 개인이 앓고있는 질병입니다. 탈모증 치료는 발모 촉진, 개인에 맞는 치료 전략의 고안, 병용 요법의 활용, 탈모의 신체적 증상의 관리 등 탈모의 다양한 측면을 다루는 데 중요한 역할을 하고 있습니다. 이러한 개입은 개인의 영적 행복과 전반적인 삶의 질을 크게 향상시킬 수 있습니다. 예를 들어, 2023년 4월 기준 중국을 거점으로 하는 국가위생위원회의 데이터에 따르면 2억 5,000만명 이상의 중국인이 탈모를 경험했으며, 그중 42%가 26-30세의 범위에 포함되었습니다. 게다가 미국 통계 뇌실의 2023년 2월 데이터에 따르면 남성의 약 40%가 35세까지 현저한 탈모를 경험했으며, 이 비율은 60세까지 65%로 증가했다고 합니다. 따라서, 탈모 증가가 탈모증 시장 확대의 주요인이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

KTH
영문 목차

영문목차

Alopecia is a medical term describing the loss of hair, which can occur naturally, be associated with illnesses or the use of specific medications. It can manifest as localized or diffuse, temporary or permanent, and affect individuals of all ages and both genders. Treatment for alopecia aims to slow down, reverse, or manage hair loss and encourage regrowth in affected areas.

The primary types of alopecia include alopecia areata, androgenetic alopecia, alopecia totalis, traction alopecia, cicatricial alopecia, and others. Alopecia areata is an autoimmune condition characterized by sudden hair loss resulting in circular or oval patches on the scalp or other body areas. Various treatment options encompass pharmaceuticals, low-level laser therapy devices, hair transplants, regenerative medicine, and more. These treatments are available through diverse distribution channels like hospital pharmacies, retail pharmacies, online pharmacies, and others, catering to a wide range of end-users including dermatology clinics, home care settings, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The alopecia market research report is one of a series of new reports from The Business Research Company that provides alopecia market statistics, including alopecia industry global market size, regional shares, competitors with an alopecia market share, detailed alopecia market segments, market trends and opportunities and any further data you may need to thrive in the alopecia industry. This alopecia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alopecia market size has grown steadily in recent years. It will grow from $11.08 billion in 2024 to $11.48 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to growing awareness of diagnosis, increasing consumer demand, increasing number of international medical tourism centers, improved reimbursement scenarios.

The alopecia market size is expected to see steady growth in the next few years. It will grow to $13.64 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to increasing aging population, rising cosmetic concerns, increasing lifestyle factors, rising healthcare expenditure. Major trends in the forecast period include advancements in treatment options, biotechnological innovations, the growing use of artificial intelligence (AI) and machine learning (ML) in alopecia research.

The forecast of 4.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. dermatology by restricting access to JAK inhibitor medications and laser therapy devices imported from Israel and Italy, potentially worsening hair regrowth outcomes and increasing trichology clinic expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in the prevalence of hair loss is expected to drive the growth of the alopecia market in the coming years. Hair loss, characterized by the partial or complete loss of hair from its typical growth areas, is a condition that affects many individuals. Alopecia treatments play a crucial role in addressing various aspects of hair loss, including promoting hair regrowth, devising personalized treatment strategies, utilizing combination therapies, and managing the physical manifestations of hair loss. These interventions can significantly enhance an individual's emotional well-being and overall quality of life. For example, as of April 2023, data from the China-based National Health Commission indicates that over 250 million Chinese people have experienced hair loss, with 42% of them falling within the age range of 26 to 30. Additionally, data from the US-based Statistic Brain Research Institute in February 2023 reveals that approximately 40% of men will experience noticeable hair loss by the age of 35, and this percentage will increase to 65% by the age of 60. Hence, the growing prevalence of hair loss is a key driver behind the expansion of the alopecia market.

The substantial increase in government initiatives is poised to drive the growth of the alopecia market in the future. Government initiatives encompass specific actions, policies, programs, or projects undertaken by government authorities at various levels to address particular issues, achieve specific objectives, or enhance the overall well-being of their constituents and society as a whole. Government initiatives can significantly contribute to the advancement of alopecia treatment through various means, such as allocating funds for research, expediting the approval process for new drugs and therapies, and launching public awareness campaigns to educate both the public and healthcare professionals about alopecia. As an illustration, in June 2022, the Government of Ireland, as reported by gov.ie, introduced a new grant of $525.36 (€500) to assist individuals experiencing hair loss due to illness in covering the costs of wigs, hairpieces, or other hair replacements. Such initiatives can notably enhance the quality of life for those dealing with alopecia and related conditions. Consequently, the upsurge in government initiatives is a driving force behind the growth of the alopecia market.

Major companies operating in the alopecia market are focused on developing an innovative treatments to gain competitive advantages in the market. For instance, in June 2022, Eli Lilly and Company, a US-based pharmaceutical company and Incyte, a US-based pharmaceutical company, unveiled their approval for is luminant oral tablets by the United States Food and Drug Administration (FDA), a US-based federal agency. It is the first FDA-approved systemic treatment for treating severe alopecia areata in adults. Olumiant is also indicated for treating adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more tumor necrosis factor (TNF) blockers.

In March 2023, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, acquired Concert Pharmaceuticals for $576 million. With this acquisition, Sun Pharmaceutical aims to improve and enhance its alopecia treatment offerings and expand its product portfolio. Concert Pharmaceuticals Inc. is a US-based biopharmaceutical company involved in developing oral inhibitors of Janus kinases as a treatment for alopecia areata.

Major companies operating in the alopecia market are Pfizer Inc., Johnson and Johnson Ltd., Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi SA, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Allergan PLC, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Intertek Group PLC, Dr. Reddy's Laboratories Ltd., Cipla Limited, Almirall S.A., Aclaris Therapeutics Inc., Curallux LLC, Theradome Inc., Lexington International LLC, Histogen Inc., Apira Science Inc.

North America was the largest region in the alopecia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alopecia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the alopecia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The alopecia market consists of revenues earned by entities by providing anagen effluvium, telogen effluvium, and alopecia universalis treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The alopecia market also includes the sales of shampoos, drugs, and hair regrowth supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alopecia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alopecia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for alopecia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The alopecia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Alopecia Market Characteristics

3. Alopecia Market Trends And Strategies

4. Alopecia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Alopecia Growth Analysis And Strategic Analysis Framework

6. Alopecia Market Segmentation

7. Alopecia Market Regional And Country Analysis

8. Asia-Pacific Alopecia Market

9. China Alopecia Market

10. India Alopecia Market

11. Japan Alopecia Market

12. Australia Alopecia Market

13. Indonesia Alopecia Market

14. South Korea Alopecia Market

15. Western Europe Alopecia Market

16. UK Alopecia Market

17. Germany Alopecia Market

18. France Alopecia Market

19. Italy Alopecia Market

20. Spain Alopecia Market

21. Eastern Europe Alopecia Market

22. Russia Alopecia Market

23. North America Alopecia Market

24. USA Alopecia Market

25. Canada Alopecia Market

26. South America Alopecia Market

27. Brazil Alopecia Market

28. Middle East Alopecia Market

29. Africa Alopecia Market

30. Alopecia Market Competitive Landscape And Company Profiles

31. Alopecia Market Other Major And Innovative Companies

32. Global Alopecia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Alopecia Market

34. Recent Developments In The Alopecia Market

35. Alopecia Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기